Edwards Lifesciences (EW) is a publicly traded Healthcare sector company. As of July 11, 2026, EW trades at $92.21 with a market cap of $52.59B and a P/E ratio of 48.51. EW moved +0.96% today. Year to date, EW is +8.16%; over the trailing twelve months it is +17.02%. Its 52-week range spans $65.94 to $96.29. Analyst consensus is strong buy with an average price target of $99.57. Rallies surfaces EW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for EW shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $92.21 |
| Market Cap | $52.59B |
| P/E Ratio | 48.51 |
| EPS | $1.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $96.29 |
| 52-Week Low | $65.94 |
| Volume | 2.48M |
| Avg Volume | 0 |
| Revenue (TTM) | $6.30B |
| Net Income | $1.09B |
| Gross Margin | 77.87% |
18 analysts cover EW: 0 strong buy, 14 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $99.57.